The H2 subtype of HL described by Alig et al. shares features of our subgroup of HLA‐I+ HL like the presence of EBV, high level of CD8+ T cells, and low expression of CCL17/TARC. The gene discussed is CCL17; the disease is Hodgkins lymphoma.